Sohn Min-Woong, Epstein Noam, Huang Elbert S, Huo Zhiping, Emanuele Nicholas, Stukenborg George, Guihan Marylou, Li Junping, Budiman-Mak Elly
Department of Public Health Sciences, School of Medicine, University of Virginia, PO Box 800717, Charlottesville, VA 22908.
Medical and Research Services, Hines VA Hospital, 5000 South 5th Avenue, Hines, IL 60141.
J Diabetes Complications. 2017 Jan;31(1):195-201. doi: 10.1016/j.jdiacomp.2016.09.003. Epub 2016 Sep 14.
To examine the relationship between systolic blood pressure (SBP) variability and the risk of microvascular complications in a non-elderly diabetic population.
This is a retrospective cohort study of individuals aged ≤60years treated for diabetes in 2003 in the US Department of Veterans Affairs healthcare system. Individuals were followed for five years for any new diagnosis of diabetic nephropathy, retinopathy, or neuropathy. In each year of follow-up, individuals were classified into quartiles based on their SBP variability.
We identified 208,338 patients with diabetes without diabetic nephropathy, retinopathy, or neuropathy at baseline. Compared to individuals with the least SBP variability (Quartile 1), those with most variability (Quartile 4) had 81% (OR=1.81; 95% CI, 1.72-1.91), 17% (OR=1.17; 95% CI, 1.13-1.21), 30% (OR=1.30; 95% CI, 1.25-1.35), and 19% (OR=1.19; 95% CI, 1.15-1.23) higher incidence of nephropathy, retinopathy, neuropathy, and any complication, respectively, after adjusting for mean SBP, demographic and clinical factors.
We found a significant graded relationship between SBP variability and the incidence of each complication and of any combined endpoint. This is the first study showing a significant association between SBP variability and the risk of diabetic retinopathy and neuropathy.
研究非老年糖尿病患者收缩压(SBP)变异性与微血管并发症风险之间的关系。
这是一项对2003年在美国退伍军人事务部医疗系统接受糖尿病治疗的60岁及以下个体进行的回顾性队列研究。对个体进行了为期五年的随访,以观察是否有糖尿病肾病、视网膜病变或神经病变的新诊断。在随访的每一年,根据个体的SBP变异性将其分为四分位数。
我们确定了208338例基线时无糖尿病肾病、视网膜病变或神经病变的糖尿病患者。与SBP变异性最小的个体(四分位数1)相比,变异性最大的个体(四分位数4)在调整平均SBP、人口统计学和临床因素后,肾病、视网膜病变、神经病变和任何并发症的发病率分别高81%(OR=1.81;95%CI,1.72-1.91)、17%(OR=1.17;95%CI,1.13-1.21)、30%(OR=1.30;95%CI,1.25-1.35)和19%(OR=1.19;95%CI,1.15-1.23)。
我们发现SBP变异性与每种并发症及任何综合终点的发病率之间存在显著的分级关系。这是第一项显示SBP变异性与糖尿病视网膜病变和神经病变风险之间存在显著关联的研究。